A Study of AL102 in Patients With Progressing Desmoid Tumors
A phase 2/3 trial testing Varegacestat in desmoid tumour, active and no longer recruiting.
Overview
A Study of AL102 in Patients With Progressing Desmoid Tumours is a phase 2/3 interventional study registered as NCT04871282, led by Immunome, and active but no longer recruiting when checked on 2026-09-11. Official title: RINGSIDE: A Phase 2/3, Randomised, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumours. Planned enrolment is 198 participants (actual). The study started in 2021-09-01 and primary completion is expected in 2025-12-03. No results have been posted on ClinicalTrials.gov.
Setting
RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors
Phase
Phase 2/3
Sponsor
Immunome
Registry
Enrolled
198